Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385330239> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W4385330239 abstract "Abstract Background The isoxazoline fluralaner is effective for prevention of Babesia canis transmission from infected Dermacentor reticulatus ticks to dogs for 84 days in a controlled environment. This study was designed to evaluate the effectiveness of fluralaner chewable tablets for sustained prevention of B. canis infection of dogs in endemic areas under natural conditions. Methods In Europe, privately owned, clinically healthy pet dogs were enrolled and randomized either to receive fluralaner at 25–56 mg/kg (Bravecto ® chewable tablets) on days 0 and 84, or to remain untreated during the D. reticulatus season. Blood samples were collected to evaluate B. canis exposure: on days 0 and 21 (exposure before day 0), during the study and at the end of the tick season (dogs suspected of having become infected after day 0). Efficacy was determined by the percentage reduction in B. canis transmission risk based on the difference in B. canis -positive tests in fluralaner-treated dogs compared with untreated dogs. In addition, ticks collected at monthly intervals throughout the study were identified to species level and females tested for B. canis DNA. Results A total of 152 dogs were enrolled in the study, although nine dogs were excluded because they tested positive for B. canis DNA or antibodies within 21 days after enrollment. During the study period, no fluralaner-treated dog became positive for B. canis , resulting in calculated efficacy of 100%. However, babesiosis infection was diagnosed in five untreated control dogs (Fisher’s exact test, left-sided, P = 0.0312). Tick analyses revealed that one sample collected in Hungary was infected with B. canis . Conclusion Oral administration of Bravecto chewable tablets at the recommended dosage to dogs completely prevented B. canis transmission under field conditions in an endemic area for 12 weeks. Graphical Abstract" @default.
- W4385330239 created "2023-07-29" @default.
- W4385330239 creator A5036583091 @default.
- W4385330239 creator A5046775416 @default.
- W4385330239 creator A5063976541 @default.
- W4385330239 creator A5067203713 @default.
- W4385330239 creator A5068294077 @default.
- W4385330239 creator A5075331609 @default.
- W4385330239 creator A5086755134 @default.
- W4385330239 creator A5090477129 @default.
- W4385330239 creator A5092777422 @default.
- W4385330239 date "2023-07-27" @default.
- W4385330239 modified "2023-10-17" @default.
- W4385330239 title "Field efficacy of fluralaner (Bravecto® chewable tablets) for preventing Babesia canis infection transmitted by Dermacentor reticulatus ticks to dogs" @default.
- W4385330239 cites W1000524474 @default.
- W4385330239 cites W1576339719 @default.
- W4385330239 cites W2062148355 @default.
- W4385330239 cites W2137913153 @default.
- W4385330239 cites W2152684557 @default.
- W4385330239 cites W2163307516 @default.
- W4385330239 cites W2235591265 @default.
- W4385330239 cites W2344618349 @default.
- W4385330239 cites W2415103472 @default.
- W4385330239 cites W2418163421 @default.
- W4385330239 cites W3033217403 @default.
- W4385330239 cites W3162503199 @default.
- W4385330239 cites W3200109621 @default.
- W4385330239 cites W4211025802 @default.
- W4385330239 cites W4223957845 @default.
- W4385330239 cites W4229067805 @default.
- W4385330239 doi "https://doi.org/10.1186/s13071-023-05820-2" @default.
- W4385330239 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37501160" @default.
- W4385330239 hasPublicationYear "2023" @default.
- W4385330239 type Work @default.
- W4385330239 citedByCount "0" @default.
- W4385330239 crossrefType "journal-article" @default.
- W4385330239 hasAuthorship W4385330239A5036583091 @default.
- W4385330239 hasAuthorship W4385330239A5046775416 @default.
- W4385330239 hasAuthorship W4385330239A5063976541 @default.
- W4385330239 hasAuthorship W4385330239A5067203713 @default.
- W4385330239 hasAuthorship W4385330239A5068294077 @default.
- W4385330239 hasAuthorship W4385330239A5075331609 @default.
- W4385330239 hasAuthorship W4385330239A5086755134 @default.
- W4385330239 hasAuthorship W4385330239A5090477129 @default.
- W4385330239 hasAuthorship W4385330239A5092777422 @default.
- W4385330239 hasBestOaLocation W43853302391 @default.
- W4385330239 hasConcept C159047783 @default.
- W4385330239 hasConcept C159654299 @default.
- W4385330239 hasConcept C18903297 @default.
- W4385330239 hasConcept C203014093 @default.
- W4385330239 hasConcept C2776127032 @default.
- W4385330239 hasConcept C2776262250 @default.
- W4385330239 hasConcept C2778145968 @default.
- W4385330239 hasConcept C2779557943 @default.
- W4385330239 hasConcept C2779620486 @default.
- W4385330239 hasConcept C2780581805 @default.
- W4385330239 hasConcept C2781246620 @default.
- W4385330239 hasConcept C2910225459 @default.
- W4385330239 hasConcept C42972112 @default.
- W4385330239 hasConcept C45189115 @default.
- W4385330239 hasConcept C71924100 @default.
- W4385330239 hasConcept C74714110 @default.
- W4385330239 hasConcept C86803240 @default.
- W4385330239 hasConceptScore W4385330239C159047783 @default.
- W4385330239 hasConceptScore W4385330239C159654299 @default.
- W4385330239 hasConceptScore W4385330239C18903297 @default.
- W4385330239 hasConceptScore W4385330239C203014093 @default.
- W4385330239 hasConceptScore W4385330239C2776127032 @default.
- W4385330239 hasConceptScore W4385330239C2776262250 @default.
- W4385330239 hasConceptScore W4385330239C2778145968 @default.
- W4385330239 hasConceptScore W4385330239C2779557943 @default.
- W4385330239 hasConceptScore W4385330239C2779620486 @default.
- W4385330239 hasConceptScore W4385330239C2780581805 @default.
- W4385330239 hasConceptScore W4385330239C2781246620 @default.
- W4385330239 hasConceptScore W4385330239C2910225459 @default.
- W4385330239 hasConceptScore W4385330239C42972112 @default.
- W4385330239 hasConceptScore W4385330239C45189115 @default.
- W4385330239 hasConceptScore W4385330239C71924100 @default.
- W4385330239 hasConceptScore W4385330239C74714110 @default.
- W4385330239 hasConceptScore W4385330239C86803240 @default.
- W4385330239 hasIssue "1" @default.
- W4385330239 hasLocation W43853302391 @default.
- W4385330239 hasLocation W43853302392 @default.
- W4385330239 hasLocation W43853302393 @default.
- W4385330239 hasOpenAccess W4385330239 @default.
- W4385330239 hasPrimaryLocation W43853302391 @default.
- W4385330239 hasRelatedWork W1250022585 @default.
- W4385330239 hasRelatedWork W1965377447 @default.
- W4385330239 hasRelatedWork W2001846159 @default.
- W4385330239 hasRelatedWork W2108098449 @default.
- W4385330239 hasRelatedWork W2179585019 @default.
- W4385330239 hasRelatedWork W2615337745 @default.
- W4385330239 hasRelatedWork W3201612067 @default.
- W4385330239 hasRelatedWork W4309213500 @default.
- W4385330239 hasRelatedWork W4385330239 @default.
- W4385330239 hasRelatedWork W3145532800 @default.
- W4385330239 hasVolume "16" @default.
- W4385330239 isParatext "false" @default.
- W4385330239 isRetracted "false" @default.
- W4385330239 workType "article" @default.